Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Emergent BioSolutions Inc (NYSE:EBS)

38.52
Delayed Data
As of 4:02pm ET
 -0.68 / -1.73%
Today’s Change
27.68
Today|||52-Week Range
40.96
-3.72%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Operating ActivitiesNet Income / Starting Line18.1M32.0M44.0M62.9M
 
 
 
 
 
Depreciation11.2M19.0M32.5M35.3M
 
 
 
 
 
Total Other Cash Flow19.8M8.0M5.9M8.7M
 
 
 
 
 
Funds From Operations52.5M72.8M98.8M110.4M
 
 
 
 
 
Funds From/For Other Operating Expenses12.8M-24.1M-13.5M65.9M
 
 
 
 
 
Net Cash Flow - Operating Activities39.6M97.0M112.3M44.5M
 
 
 
 
 
 
InvestingDecrease In Investments2.0M0.000.000.00
 
 
Capital Expenditures-53.8M-42.0M-30.7M-44.8M
 
 
 
 
 
Fixed Asset Disposal11.8M0.00----
 
 
Net Assets From Acquisitions 0.00-25.9M-179.4M-650.0K
 
 
 
 
Net Cash Flow Investing-40.1M-67.9M-210.1M-45.5M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.00----
Long Term Borrowings13.5M62.0M242.6M2.0M
 
 
 
 
 
Long Term Debt Reduction-10.2M-62.8M-62.0M0.00
 
 
 
 
Net Proceeds Stock Sale761.0K6.8M14.1M26.0M
 
 
 
 
 
Common Preferred Redeemed-5.9M-213.0K-200.0K-100.0K
 
 
 
 
 
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing1.8M3.1M6.0M11.3M
 
 
 
 
 
Other Uses - Financing1.7M348.0K1.6M5.7M
 
 
 
 
 
Net Cash Flow - Financing-1.8M8.6M198.9M33.4M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash1.0K-14.0K21.0K-150.0K
 
 
 
 
 
 
Net Change In Cash-2.2M37.7M101.1M32.4M